Home
Why These 10 Stocks Are Moving Today: November 2, 2026
Back to Blog
Market News

Why These 10 Stocks Are Moving Today: November 2, 2026

November 2, 20265 min read

Your free trial has ended

Unlock lifetime access to every AI research tool for a one-time payment of $19.99.

Narrated by Josh
Share

The market is seeing significant volatility today, led by a massive breakout in the biotech sector and unusual volume across several small-cap equities. Inovio Pharmaceuticals is the standout performer, driving the day's momentum alongside other notable movers like ClearOne and INLIF Limited. Investors are closely monitoring these high-volume shifts as the session progresses.

INO (Inovio Pharmaceuticals, Inc.) — up 193.0% Inovio Pharmaceuticals is surging today following the U.S. FDA's accelerated approval of VOCERYQ, the company's first commercial DNA-based immunotherapy designed to reduce surgical interventions for adults with recurrent respiratory papillomatosis. Additionally, the company recently secured an $80.4 million court judgment against VGXI and GeneOne regarding a supply agreement breach. The move began in pre-market trading and has sustained high momentum throughout the early session, with volume reaching 20.9x its 3-month average. What to watch next: The company is targeting a commercial launch for VOCERYQ in Q1 2027.

See our full AI breakdown of INO — free

CLRO (ClearOne, Inc.) — up 77.7% ClearOne is seeing a sharp rally today on 7.6x its normal trading volume. The move follows recent market attention regarding a potential merger timeline involving Vivani Medical. The stock began its ascent early in the session. What to watch next: Monitor for further updates regarding the definitive merger agreement and regulatory filings.

See our full AI breakdown of CLRO — free

INLF (INLIF Limited) — up 74.6% INLIF Limited is experiencing a massive surge in activity, trading at 38.5x its 3-month average volume. The move, which began early in the session, reflects significant intraday interest. What to watch next: Watch for any official company disclosures or filings that may explain this unusual volume spike.

See our full AI breakdown of INLF — free

RBNE (Robin Energy Ltd.) — up 52.1% Robin Energy is moving higher on 24.8x its average volume. The stock saw heavy buying pressure early in the session. What to watch next: Keep an eye on sector-wide energy trends and any potential news from the company.

See our full AI breakdown of RBNE — free

EVGO (EVgo, Inc.) — up 49.3% EVgo is rallying on 13.5x its 3-month average volume. The move gained traction shortly after the market open. What to watch next: Watch for developments in the EV infrastructure space.

See our full AI breakdown of EVGO — free

ATII (Archimedes Tech SPAC Partners II Co) — up 36.8% Archimedes Tech SPAC Partners II is up 36.8% on 214.5K volume. This move was detected during the early session as part of a broader scan of high-performing equities. What to watch next: Monitor for any news regarding potential business combinations.

See our full AI breakdown of ATII — free

ADIL (Adial Pharmaceuticals, Inc.) — up 36.1% Adial Pharmaceuticals is climbing on 83.1K volume. The stock has shown strong intraday momentum since the opening bell. What to watch next: Watch for updates on the company's clinical pipeline.

See our full AI breakdown of ADIL — free

WETO (Wetour Robotics Limited) — up 34.2% Wetour Robotics is surging on 2.4x its 3-month average volume. The stock has been active throughout the morning session. What to watch next: Monitor for any new product announcements or partnership news.

See our full AI breakdown of WETO — free

PERI (Perion Network Ltd.) — up 31.0% Perion Network is moving on news that Affle will acquire the company for $11.70 per share in cash. The move began in pre-market trading and has seen 13.2x its average volume. What to watch next: The go-shop deadline is scheduled for December 11, 2026.

See our full AI breakdown of PERI — free

GLMD (Galmed Pharmaceuticals Ltd.) — up 21.1% Galmed Pharmaceuticals is rallying on 39.8x its 3-month average volume. The move was identified as unusual intraday activity. What to watch next: Watch for any upcoming clinical trial data or regulatory updates.

See our full AI breakdown of GLMD — free

What Other Outlets Are Reporting * Inovio Wins FDA Approval for VOCERYQ (FinancialContent) * INO Surges After FDA Approval (StocksToTrade) * FDA Approves INOVIO's First DNA Immunotherapy (MyChesCo)

See our full AI breakdown of FDA — free

Key Takeaways * Biotech stocks are dominating the top movers list today, led by Inovio's major FDA approval. * M&A activity is driving significant price action for companies like Perion Network. * Unusual volume is a common theme across today's movers, with several stocks trading at multiples of their 3-month averages. * Investors should remain cautious of high volatility in low-float or small-cap names. Disclaimer: This article is for informational purposes only and does not constitute financial advice. Always conduct your own research before making investment decisions.

See our full AI breakdown of FDA — free

Analyze INO with the same AI

Run any ticker through Stockinhood's AI research tools free for 15 minutes — no card required.

Open INO in the free tools
INO CLRO INLF RBNE EVGO ATII ADIL WETO PERI GLMD stock movers why is it moving

Stockinhood AI

AI-Generated Content

Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice. All AI-generated content should be independently verified. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.